I caught this last night on GeekWire. And I expected to see a lot more when I got up this morning. But I’m not really finding much. So it kind of became one of those “Did I just imagine that…?” But, nope. It’s real. I’m just not seeing much about it. So let’s get into it. Portland’s Reperio Health just raised $14 million and signed a deal with Uber.
The company has raised a total of $20 million, and is looking to raise an additional $10 million or more to support this broader mission. It’s also talking to manufacturers of other biometric devices to eventually expand the suite of tests provided. Reperio has 24 employees.
The latest funding includes investors from the company’s 2021 seed round: Nashville’s Caduceus Capital Partners; Oregon’s Rogue Venture Partners and Portland Seed Fund; and Liquid 2 Ventures in San Francisco. Angel investors also participated in the round.
The news also included a mention of a deal with Uber to deliver Reperio’s kits to users in under an hour.
So what does Reperio Health do that would convince VCs to invest in this economic environment?
Reperio was created to address strain and inefficiency in the healthcare system and bring convenient screening solutions to consumers, employers and providers.
Today, Reperio’s flagship wellness kit enables individuals to measure blood pressure, cholesterol, glucose and more from home with instant results, but the future is limitless. Our patented screening technology enables us to add any Bluetooth-connected medical device to a screening kit, opening up the door for STI kits, A1C, and more.
I’ll keep tracking on this one in case other folks cover it. But I wanted to post so that folks were aware.
For more information, visit Reperio Health. Or see the Portland Business Journal coverage.
More news from this week
